A Historical-Controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400 mg/day Monotherapy in Subjects with Partial-Onset Seizure (SP902)
- Bensalem Owen, Meriem (PI)
- Fakhoury, Toufic (Former PI)